Cargando…
Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862411/ https://www.ncbi.nlm.nih.gov/pubmed/31535650 http://dx.doi.org/10.4103/1673-5374.264458 |
| _version_ | 1783471547991719936 |
|---|---|
| author | Brunetti, Leonardo Laghezza, Antonio Loiodice, Fulvio Tortorella, Paolo Piemontese, Luca |
| author_facet | Brunetti, Leonardo Laghezza, Antonio Loiodice, Fulvio Tortorella, Paolo Piemontese, Luca |
| author_sort | Brunetti, Leonardo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6862411 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68624112020-01-02 Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease Brunetti, Leonardo Laghezza, Antonio Loiodice, Fulvio Tortorella, Paolo Piemontese, Luca Neural Regen Res Perspective Wolters Kluwer - Medknow 2019-09-16 /pmc/articles/PMC6862411/ /pubmed/31535650 http://dx.doi.org/10.4103/1673-5374.264458 Text en Copyright: © Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Perspective Brunetti, Leonardo Laghezza, Antonio Loiodice, Fulvio Tortorella, Paolo Piemontese, Luca Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease |
| title | Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease |
| title_full | Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease |
| title_fullStr | Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease |
| title_full_unstemmed | Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease |
| title_short | Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease |
| title_sort | combining fatty acid amide hydrolase (faah) inhibition with peroxisome proliferator-activated receptor (ppar) activation: a new potential multi-target therapeutic strategy for the treatment of alzheimer’s disease |
| topic | Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862411/ https://www.ncbi.nlm.nih.gov/pubmed/31535650 http://dx.doi.org/10.4103/1673-5374.264458 |
| work_keys_str_mv | AT brunettileonardo combiningfattyacidamidehydrolasefaahinhibitionwithperoxisomeproliferatoractivatedreceptorpparactivationanewpotentialmultitargettherapeuticstrategyforthetreatmentofalzheimersdisease AT laghezzaantonio combiningfattyacidamidehydrolasefaahinhibitionwithperoxisomeproliferatoractivatedreceptorpparactivationanewpotentialmultitargettherapeuticstrategyforthetreatmentofalzheimersdisease AT loiodicefulvio combiningfattyacidamidehydrolasefaahinhibitionwithperoxisomeproliferatoractivatedreceptorpparactivationanewpotentialmultitargettherapeuticstrategyforthetreatmentofalzheimersdisease AT tortorellapaolo combiningfattyacidamidehydrolasefaahinhibitionwithperoxisomeproliferatoractivatedreceptorpparactivationanewpotentialmultitargettherapeuticstrategyforthetreatmentofalzheimersdisease AT piemonteseluca combiningfattyacidamidehydrolasefaahinhibitionwithperoxisomeproliferatoractivatedreceptorpparactivationanewpotentialmultitargettherapeuticstrategyforthetreatmentofalzheimersdisease |